Business Description
Cell Impact
ISIN : SE0017885379
Share Class Description:
OSTO:CI: Class BCompare
Compare
Traded in other countries / regions
CI.SwedenICLA.Germany IPO Date
2013-02-20Description
Cell Impact develops technologies to produce flow plates for fuel cells. It provides graphite, stainless steel, and titanium flow plates. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming that makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional molding methods.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.56 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -0.53 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.61 | |||||
| Beneish M-Score | -0.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 32.6 | |||||
| 3-Year EBITDA Growth Rate | -55.6 | |||||
| 3-Year EPS without NRI Growth Rate | -58.5 | |||||
| 3-Year FCF Growth Rate | -47.1 | |||||
| 3-Year Book Growth Rate | -20.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 64 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 60.13 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.52 | |||||
| 9-Day RSI | 35.81 | |||||
| 14-Day RSI | 39.35 | |||||
| 6-1 Month Momentum % | 58.84 | |||||
| 12-1 Month Momentum % | 2.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.45 | |||||
| Quick Ratio | 1.88 | |||||
| Cash Ratio | 0.8 | |||||
| Days Inventory | 785.3 | |||||
| Days Sales Outstanding | 78.3 | |||||
| Days Payable | 116.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -44.1 | |||||
| Shareholder Yield % | 1.84 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.3 | |||||
| Operating Margin % | -262.16 | |||||
| Net Margin % | -268.73 | |||||
| FCF Margin % | -367.66 | |||||
| ROE % | -39.59 | |||||
| ROA % | -31.23 | |||||
| ROIC % | -37.96 | |||||
| 3-Year ROIIC % | -39.96 | |||||
| ROC (Joel Greenblatt) % | -43.3 | |||||
| ROCE % | -34.17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.23 | |||||
| PB Ratio | 0.46 | |||||
| Price-to-Tangible-Book | 0.48 | |||||
| EV-to-EBIT | -1.53 | |||||
| EV-to-EBITDA | -2.07 | |||||
| EV-to-Revenue | 3.97 | |||||
| EV-to-FCF | -1.08 | |||||
| Price-to-Median-PS-Value | 0.09 | |||||
| Price-to-Net-Current-Asset-Value | 2.86 | |||||
| Earnings Yield (Greenblatt) % | -65.36 | |||||
| FCF Yield % | -104.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cell Impact Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 39.714 | ||
| EPS (TTM) (kr) | -0.248 | ||
| Beta | 2.45 | ||
| Volatility % | 174.81 | ||
| 14-Day RSI | 39.35 | ||
| 14-Day ATR (kr) | 0.01584 | ||
| 20-Day SMA (kr) | 0.2128 | ||
| 12-1 Month Momentum % | 2.63 | ||
| 52-Week Range (kr) | 0.1202 - 1.49 | ||
| Shares Outstanding (Mil) | 696.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cell Impact Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cell Impact Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cell Impact Frequently Asked Questions
What is Cell Impact(OSTO:CI)'s stock price today?
The current price of OSTO:CI is kr0.20. The 52 week high of OSTO:CI is kr1.49 and 52 week low is kr0.12.
When is next earnings date of Cell Impact(OSTO:CI)?
The next earnings date of Cell Impact(OSTO:CI) is 2024-11-06.
Does Cell Impact(OSTO:CI) pay dividends? If so, how much?
Cell Impact(OSTO:CI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers